Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article in which an immunocytokine, NHS-muIL12, which consists of two molecules of murine IL-12 fused to NHS76, a tumor necrosis-targeting human IgG1, was examined as an immunotherapeutic in an orthotopic MB49 luc ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article demonstrating that high numbers of peripheral CD8 T cells expressing differentiation markers and lacking co-stimulatory receptors at baseline are associated with response to nivolumab in NSCLC patients. Authors: ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a short report on the final planned analysis of OPTiM, a randomized open-label phase III trial of T-vec in patients with unresectable stage IIIB–IVM1c melanoma. Authors: Robert H. I. Andtbacka , Frances Collichio , Kevin J....
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article reporting the results of a phase I study that evaluated the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of weekly ONC201. Authors: Mark N. Stein , Jyoti Malhotra , Rohinton S. Tarapore , Usha...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report describing a patient with myasthenia gravis treated with pembrolizumab demonstrating successful outcomes. Authors: Anne Zaremba , Eleftheria Chorti , Finja Jockenhöfer , Saskia Bolz , Selma Sirin , Martin Glas ,...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article investigating the correlation of tumor infiltrating immune cell characteristics with rates of recurrence following surgery in localized ccRCC. Authors: Pooja Ghatalia , Jennifer Gordetsky , Fengshen Kuo , ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article establishing a novel NK cell line, NK101, from a patient with extra-nodal natural killer/T-cell lymphoma and examining its phenotypic, genomic and functional characteristics. Authors: Hyun Gul Yang , Moon...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article seeking to map the immune landscape of BrC SLN Authors: Kim M. van Pul , Ronald J.C.L.M. Vuylsteke , Rieneke van de Ven , Elisabeth A. te Velde , Emiel J. Th. Rutgers , Petrousjka M. van den Tol , Hein B.A...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article concluding that ICIs produce a spectrum of distinct classes of neurologic AEs that can cause significant morbidity and mortality and tend to occur early and with class-specific associations. Authors: Douglas B....
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a position article and guidelines. This paper defines ways in which treatment with I-O is different from other therapies. It also proposes key aspects and attributes of I-O therapies that should be considered in any assessment of...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us